| Monroe Community Mental Health Authority | |
|
1001 S Raisinville Rd Monroe MI 48161-9754 | |
| (734) 243-7340 | |
| (734) 243-5506 |
| Full Name | Monroe Community Mental Health Authority |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 1001 S Raisinville Rd, Monroe, Michigan |
| Authorized Official Name and Position | Jane S Terwilliger (CHIEF EXECUTIVE OFFICER) |
| Authorized Official Contact | 7342437340 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Monroe Community Mental Health Authority 1001 S Raisinville Rd Po Box 0726 Monroe MI 48161-9754 Ph: (734) 243-7340 | Monroe Community Mental Health Authority 1001 S Raisinville Rd Monroe MI 48161-9754 Ph: (734) 243-7340 |
| NPI Number | 1245303890 |
|---|---|
| Provider Enumeration Date | 11/15/2006 |
| Last Update Date | 09/25/2008 |
| Medicare PECOS PAC ID | 8325025513 |
|---|---|
| Medicare Enrollment ID | O20040706000915 |
News Archive
Health care companies stand to gain from legislation that would expand their market to millions of new consumers, but many are also complaining about specific provisions of the House health care overhaul bill, the New York Times reports.
Research shows that high serum levels of interleukin-10 indicate that the likely cause of acute otitis media is infection with Streptococcus pneumoniae, as opposed to Haemophilus influenzae or Moraxella catarrhalis.
Blacks have a higher incidence of stroke and stroke-associated disability than whites. However, few studies have evaluated racial differences in stroke before a diagnosis of atrial fibrillation (AF).
People with disabilities have unmet medical needs and poorer overall health throughout their lives, and as a result should be recognized as a health disparity group so more attention can be directed to improving their quality of life, a team of policy researchers has found.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245303890 | NPI | - | NPPES |
| 4355907 | Medicaid | MI | |
| 4456552 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
| Provider Name | Paul Y Gutterman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629140611 PECOS PAC ID: 5496719346 Enrollment ID: I20041122000168 |
News Archive
Health care companies stand to gain from legislation that would expand their market to millions of new consumers, but many are also complaining about specific provisions of the House health care overhaul bill, the New York Times reports.
Research shows that high serum levels of interleukin-10 indicate that the likely cause of acute otitis media is infection with Streptococcus pneumoniae, as opposed to Haemophilus influenzae or Moraxella catarrhalis.
Blacks have a higher incidence of stroke and stroke-associated disability than whites. However, few studies have evaluated racial differences in stroke before a diagnosis of atrial fibrillation (AF).
People with disabilities have unmet medical needs and poorer overall health throughout their lives, and as a result should be recognized as a health disparity group so more attention can be directed to improving their quality of life, a team of policy researchers has found.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
› Verified 8 days ago
| Provider Name | Manish Prasad |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1558395947 PECOS PAC ID: 8325096340 Enrollment ID: I20050106000592 |
News Archive
Health care companies stand to gain from legislation that would expand their market to millions of new consumers, but many are also complaining about specific provisions of the House health care overhaul bill, the New York Times reports.
Research shows that high serum levels of interleukin-10 indicate that the likely cause of acute otitis media is infection with Streptococcus pneumoniae, as opposed to Haemophilus influenzae or Moraxella catarrhalis.
Blacks have a higher incidence of stroke and stroke-associated disability than whites. However, few studies have evaluated racial differences in stroke before a diagnosis of atrial fibrillation (AF).
People with disabilities have unmet medical needs and poorer overall health throughout their lives, and as a result should be recognized as a health disparity group so more attention can be directed to improving their quality of life, a team of policy researchers has found.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
› Verified 8 days ago
| Provider Name | Kim Horn |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497778617 PECOS PAC ID: 7517967680 Enrollment ID: I20070115000171 |
News Archive
Health care companies stand to gain from legislation that would expand their market to millions of new consumers, but many are also complaining about specific provisions of the House health care overhaul bill, the New York Times reports.
Research shows that high serum levels of interleukin-10 indicate that the likely cause of acute otitis media is infection with Streptococcus pneumoniae, as opposed to Haemophilus influenzae or Moraxella catarrhalis.
Blacks have a higher incidence of stroke and stroke-associated disability than whites. However, few studies have evaluated racial differences in stroke before a diagnosis of atrial fibrillation (AF).
People with disabilities have unmet medical needs and poorer overall health throughout their lives, and as a result should be recognized as a health disparity group so more attention can be directed to improving their quality of life, a team of policy researchers has found.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
› Verified 8 days ago
| Provider Name | Pasha M Streeter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922322684 PECOS PAC ID: 4385874015 Enrollment ID: I20160615000985 |
News Archive
Health care companies stand to gain from legislation that would expand their market to millions of new consumers, but many are also complaining about specific provisions of the House health care overhaul bill, the New York Times reports.
Research shows that high serum levels of interleukin-10 indicate that the likely cause of acute otitis media is infection with Streptococcus pneumoniae, as opposed to Haemophilus influenzae or Moraxella catarrhalis.
Blacks have a higher incidence of stroke and stroke-associated disability than whites. However, few studies have evaluated racial differences in stroke before a diagnosis of atrial fibrillation (AF).
People with disabilities have unmet medical needs and poorer overall health throughout their lives, and as a result should be recognized as a health disparity group so more attention can be directed to improving their quality of life, a team of policy researchers has found.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
› Verified 8 days ago
| Provider Name | Marialba Romero Medina |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1407040173 PECOS PAC ID: 4284939687 Enrollment ID: I20180524000242 |
News Archive
Health care companies stand to gain from legislation that would expand their market to millions of new consumers, but many are also complaining about specific provisions of the House health care overhaul bill, the New York Times reports.
Research shows that high serum levels of interleukin-10 indicate that the likely cause of acute otitis media is infection with Streptococcus pneumoniae, as opposed to Haemophilus influenzae or Moraxella catarrhalis.
Blacks have a higher incidence of stroke and stroke-associated disability than whites. However, few studies have evaluated racial differences in stroke before a diagnosis of atrial fibrillation (AF).
People with disabilities have unmet medical needs and poorer overall health throughout their lives, and as a result should be recognized as a health disparity group so more attention can be directed to improving their quality of life, a team of policy researchers has found.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
› Verified 8 days ago
News Archive
Health care companies stand to gain from legislation that would expand their market to millions of new consumers, but many are also complaining about specific provisions of the House health care overhaul bill, the New York Times reports.
Research shows that high serum levels of interleukin-10 indicate that the likely cause of acute otitis media is infection with Streptococcus pneumoniae, as opposed to Haemophilus influenzae or Moraxella catarrhalis.
Blacks have a higher incidence of stroke and stroke-associated disability than whites. However, few studies have evaluated racial differences in stroke before a diagnosis of atrial fibrillation (AF).
People with disabilities have unmet medical needs and poorer overall health throughout their lives, and as a result should be recognized as a health disparity group so more attention can be directed to improving their quality of life, a team of policy researchers has found.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
› Verified 8 days ago
Caring Alternatives Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2092 S Custer Rd, Monroe, MI 48161 Phone: 734-242-8711 Fax: 734-242-3955 | |
Puente Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2456 10th St, Monroe, MI 48162 Phone: 734-497-2951 | |
Elshaddai Counseling & Consultation Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 105 E Front St, Suite 204, Monroe, MI 48161 Phone: 734-240-0372 Fax: 734-481-0090 | |
Delaney Counseling Services Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15502 S Telegraph Rd, Monroe, MI 48161 Phone: 734-241-4851 | |
Wise Owl Counseling & Consulting Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 28 W Willow St, Monroe, MI 48162 Phone: 734-707-7315 | |
Primacare , L.l.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14930 Laplaisance Rd, #138, Monroe, MI 48161 Phone: 734-513-1122 Fax: 734-421-1405 | |
El Shaddai Counseling & Consultation Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 105 E Front St, Suite 204, Monroe, MI 48161 Phone: 734-240-0372 Fax: 734-240-0372 |